245 related articles for article (PubMed ID: 30277751)
1. New in Vivo Compatible Matrix Metalloproteinase (MMP)-2 and MMP-9 Inhibitors.
Beutel B; Song J; Konken CP; Korpos E; Schinor B; Gerwien H; Vidyadharan R; Burmeister M; Li L; Haufe G; Sorokin L
Bioconjug Chem; 2018 Nov; 29(11):3715-3725. PubMed ID: 30277751
[TBL] [Abstract][Full Text] [Related]
2. N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.
Nuti E; Cantelmo AR; Gallo C; Bruno A; Bassani B; Camodeca C; Tuccinardi T; Vera L; Orlandini E; Nencetti S; Stura EA; Martinelli A; Dive V; Albini A; Rossello A
J Med Chem; 2015 Sep; 58(18):7224-40. PubMed ID: 26263024
[TBL] [Abstract][Full Text] [Related]
3. Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.
Beutel B; Daniliuc CG; Riemann B; Schäfers M; Haufe G
Bioorg Med Chem; 2016 Feb; 24(4):902-9. PubMed ID: 26810711
[TBL] [Abstract][Full Text] [Related]
4. Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.
Yan XQ; Wang ZC; Li Z; Wang PF; Qiu HY; Chen LW; Lu XY; Lv PC; Zhu HL
Bioorg Med Chem Lett; 2015 Oct; 25(20):4664-71. PubMed ID: 26346367
[TBL] [Abstract][Full Text] [Related]
5. Functional mimetic peptide discovery isolated by phage display interacts selectively to fibronectin domain and inhibits gelatinase.
Shoari A; Rasaee MJ; Kanavi MR; Daraei B
J Cell Biochem; 2019 Dec; 120(12):19699-19711. PubMed ID: 31270859
[TBL] [Abstract][Full Text] [Related]
6. New matrix metalloproteinase inhibitors based on γ-fluorinated α-aminocarboxylic and α-aminohydroxamic acids.
Behrends M; Wagner S; Kopka K; Schober O; Schäfers M; Kumbhar S; Waller M; Haufe G
Bioorg Med Chem; 2015 Jul; 23(13):3809-18. PubMed ID: 25921268
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.
Nuti E; Casalini F; Santamaria S; Gabelloni P; Bendinelli S; Da Pozzo E; Costa B; Marinelli L; La Pietra V; Novellino E; Margarida Bernardo M; Fridman R; Da Settimo F; Martini C; Rossello A
Eur J Med Chem; 2011 Jul; 46(7):2617-29. PubMed ID: 21514700
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Biological Evaluation, and Docking of Dihydropyrazole Sulfonamide Containing 2-hydroxyphenyl Moiety: A Series of Novel MMP-2 Inhibitors.
Wang PF; Qiu HY; Baloch SK; Gong HB; Wang ZC; Zhu HL
Chem Biol Drug Des; 2015 Dec; 86(6):1405-10. PubMed ID: 26061284
[TBL] [Abstract][Full Text] [Related]
9. Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.
Adhikari N; Halder AK; Mallick S; Saha A; Saha KD; Jha T
Bioorg Med Chem; 2016 Sep; 24(18):4291-4309. PubMed ID: 27452283
[TBL] [Abstract][Full Text] [Related]
10. Novel 5-Hydroxy, 5-Substituted Benzenesulfonamide Pyrimidine-2,4,6-Triones Attenuate Lipopolysaccharide-Induced Acute Lung Injury via Inhibition of the Gelatinases, MMP-2 and MMP-9.
He W; Jiang J; Yu ZQ; Zhou JH
Drug Dev Res; 2016 Aug; 77(5):251-7. PubMed ID: 27455162
[TBL] [Abstract][Full Text] [Related]
11. Biphenyl substituted lysine derivatives as recognition elements for the matrix metalloproteinases MMP-2 and MMP-9.
Kirchhain A; Zubrienė A; Kairys V; Vivaldi F; Bonini A; Biagini D; Santalucia D; Matulis D; Di Francesco F
Bioorg Chem; 2021 Oct; 115():105155. PubMed ID: 34303036
[TBL] [Abstract][Full Text] [Related]
12. A highly soluble matrix metalloproteinase-9 inhibitor for potential treatment of dry eye syndrome.
Mori M; De Lorenzo E; Torre E; Fragai M; Nativi C; Luchinat C; Arcangeli A
Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):289-95. PubMed ID: 22520332
[TBL] [Abstract][Full Text] [Related]
13. An integrated computational and experimental approach to gaining selectivity for MMP-2 within the gelatinase subfamily.
Fabre B; Filipiak K; Díaz N; Zapico JM; Suárez D; Ramos A; de Pascual-Teresa B
Chembiochem; 2014 Feb; 15(3):399-412. PubMed ID: 24449516
[TBL] [Abstract][Full Text] [Related]
14. Insight into the structural requirement of aryl sulphonamide based gelatinases (MMP-2 and MMP-9) inhibitors - Part I: 2D-QSAR, 3D-QSAR topomer CoMFA and Naïve Bayes studies - First report of 3D-QSAR Topomer CoMFA analysis for MMP-9 inhibitors and jointly inhibitors of gelatinases together.
Das S; Amin SA; Jha T
SAR QSAR Environ Res; 2021 Aug; 32(8):655-687. PubMed ID: 34355614
[TBL] [Abstract][Full Text] [Related]
15. Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.
Tauro M; Laghezza A; Loiodice F; Agamennone M; Campestre C; Tortorella P
Bioorg Med Chem; 2013 Nov; 21(21):6456-65. PubMed ID: 24071448
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Biological Evaluation of Tetrahydro-β-carboline Derivatives as Selective Sub-Nanomolar Gelatinase Inhibitors.
Mangiatordi GF; Guzzo T; Rossano EC; Trisciuzzi D; Alberga D; Fasciglione G; Coletta M; Topai A; Nicolotti O
ChemMedChem; 2018 Jul; 13(13):1343-1352. PubMed ID: 29893479
[TBL] [Abstract][Full Text] [Related]
17. Kinetic characterization of 4,4'-biphenylsulfonamides as selective non-zinc binding MMP inhibitors.
Santamaria S; Nuti E; Cercignani G; La Regina G; Silvestri R; Supuran CT; Rossello A
J Enzyme Inhib Med Chem; 2015 Dec; 30(6):947-54. PubMed ID: 25694065
[TBL] [Abstract][Full Text] [Related]
18. Arylsulfonamides and selectivity of matrix metalloproteinase-2: An overview.
Adhikari N; Mukherjee A; Saha A; Jha T
Eur J Med Chem; 2017 Mar; 129():72-109. PubMed ID: 28219048
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and discovery of (I-3,II-3)-biacacetin as a novel non-zinc binding inhibitor of MMP-2 and MMP-9.
Nanjan P; Nambiar J; Nair BG; Banerji A
Bioorg Med Chem; 2015 Jul; 23(13):3781-7. PubMed ID: 25907368
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Gelatinases (MMP-2 and MMP-9) by Withania somnifera Phytochemicals Confers Neuroprotection in Stroke: An In Silico Analysis.
Kumar G; Patnaik R
Interdiscip Sci; 2018 Dec; 10(4):722-733. PubMed ID: 28488219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]